Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Immigrant and Minority Health
Published in: Journal of Immigrant and Minority Health 5/2013

01-10-2013 | Original Paper

Self-Reported Prior Lung Diseases as Risk Factors for Non-small Cell Lung Cancer in Mexican Americans

Authors: Michelle K. McHugh, Matthew B. Schabath, Chung-han Ho, Mei Liu, Anthony M. D’Amelio Jr., Anthony J. Greisinger, George L. Delclos, Margaret R. Spitz, Carol J. Etzel

Published in: Journal of Immigrant and Minority Health | Issue 5/2013

Login to get access

Abstract

This study was conducted to assess the association between prior history of respiratory disease and lung cancer among Mexican Americans using data from a multi-racial/ethnic lung cancer case–control study. Cases (n = 204) were patients with previously untreated lung cancer. Healthy control participants (n = 325) were recruited from a large physician group practice. Demographics, cigarette use, and history of respiratory disease were collected. Multivariable logistic regression models were used to estimate relative risk. Prior history of COPD (OR = 2.0; 95 % CI 1.2–3.3) and pneumonia (OR = 2.2; 95 % CI 1.3–3.6) were associated with an increased risk of lung cancer. These findings illustrate that prior COPD and pneumonia are associated with an increased risk of lung cancer among Mexican Americans. To our knowledge, this is one of largest case–control analyses assessing the role of respiratory disease and lung cancer risk specifically among Mexican-Americans.
Literature
1.
2.
Eschbach K, Mahnken JD, Goodwin JS. Neighborhood composition and incidence of cancer among Hispanics in the United States. Cancer. 2005;103:1036–44.PubMedCrossRef
3.
Wiencke JK, et al. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev. 1997;6(2):87–92.PubMed
4.
Smith BS, et al. Disparities in lung cancer stage, treatment and survival among American Indians and Alaskan Natives. Lung Cancer. 2011;72:160–4.PubMedCrossRef
5.
Cohen B. Introduction, Chapter 1. In: Anderson NB, Bulatao RB, Cohen B, editors. National Research Council (US) Panel on Race, Ethnicity, and Health Later in Life; Critical Perspectives on Racial and Ethnic Differences in Health in Late Life. Washington, D.C.: National Academies Press; 2004.
6.
7.
8.
Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol. 1999;149(1):13–20.PubMedCrossRef
9.
Samet JM, Humble CG, Pathak DR. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis. 1986;134(3):466–70.PubMed
10.
Alavanja MC, et al. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol. 1992;136(6):623–32.PubMed
11.
Wu-Williams AH, et al. Lung cancer among women in north-east China. Br J Cancer. 1990;62(6):982–7.PubMedCrossRef
12.
Brenner AV, et al. Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol. 2001;30(1):118–24.PubMedCrossRef
13.
Osann KE, Lowery JT, Schell MJ. Small cell lung cancer in women: risk associated with smoking, prior respiratory disease, and occupation. Lung Cancer. 2000;28:1–10.PubMedCrossRef
14.
McWhorter WP. Allergy and risk of cancer. A prospective study using NHANESI followup data. Cancer. 1988;62(2):451–5.PubMedCrossRef
15.
Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med. 1986;105(4):503–7.PubMedCrossRef
16.
Santillan AA, Camargo CA Jr, Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control. 2003;14(4):327–34.PubMedCrossRef
17.
18.
Ballaz S, Mulshine JL. The potential contribution of chronic inflammation to lung carcinogenesis. Clin Lung Cancer. 2003;5:46–62.PubMedCrossRef
19.
Peek RMJ, Mohla S, DuBois R. Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a National Cancer Institute—sponsored meeting. Cancer Res. 2005;65(19):8583–6.PubMedCrossRef
20.
Engels EA. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther. 2008;8(4):605–15.PubMedCrossRef
21.
O’Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer. 2000;85(4):473–83.CrossRef
22.
23.
Spitz MR, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007;99(9):715–26.PubMedCrossRef
24.
Etzel CJ, et al. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila Pa). 2008;1(4):255–65.CrossRef
25.
Tockman MS, et al. Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987;106(4):512–8.PubMedCrossRef
26.
Schwartz AG, et al. Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J Thorac Oncol. 2009;4(3):291–9.PubMedCrossRef
27.
Littman AJ, et al. Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control. 2004;15(8):819–27.PubMedCrossRef
28.
Koshiol J, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One. 2009;4(10):e7380.PubMedCrossRef
29.
Raherison C, Girodet P. Epidemiology of COPD. Eur Respir J. 2009;18(114):213–21.CrossRef
30.
Zhan P, et al. Chlamydia pneumonia infection and lung cancer risk: a meta-analysis. Eur J Cancer. 2011;47(5):742–7.PubMedCrossRef
31.
Koshiol J, et al. Lower risk of lung cancer after multiple pneumonia diagnoses. Cancer Epidemiol Biomarkers Prev. 2010;19(3):716–21.PubMedCrossRef
32.
Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 2005;14(4):773–8.PubMedCrossRef
33.
Grayston JT, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990;161(4):618–25.PubMedCrossRef
34.
35.
36.
Preston-Martin S, et al. Increased cell division as a cause of human cancer. Cancer Res. 1990;50:7514–21.
37.
Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nature. 2003;3:276–85.
38.
Talbot-Smith A, et al. Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am J Epidemiol. 2003;157(7):606–12.PubMedCrossRef
39.
Osann KE. Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res. 1991;51(18):4893–7.PubMed
40.
Cockcroft DW, et al. Is there a negative correlation between malignancy and respiratory atopy? Ann Allergy. 1979;43(6):345–7.PubMed
41.
Vena JE, et al. Allergy-related diseases and cancer: an inverse association. Am J Epidemiol. 1985;122(1):66–74.PubMed
42.
Gabriel R, Dudley BM, Alexander WD. Lung cancer and allergy. Br J Clin Pract. 1972;26:202–4.PubMed
43.
McDuffie HH. Atopy and primary lung cancer. Histology and sex distribution. Chest. 1991;99(2):404–7.PubMedCrossRef
44.
Schabath MB, et al. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol. 2005;161(5):412–22.PubMedCrossRef
45.
Schabath MB, Gorlova OY, Spitz MR. Re: cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol. 2006;163(4):394–5. (author reply 395–6).PubMedCrossRef
46.
Castaing M, et al. Is the risk of lung cancer reduced among eczema patients? Am J Epidemiol. 2005;162(6):542–7.PubMedCrossRef
47.
48.
Pope CA 3rd, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287(9):1132–41.PubMedCrossRef
49.
Siemiatycki J, et al. Controlling for potential confounding by occupational exposures. J Toxicol Environ Health A. 2003;66(16–19):1591–603.PubMedCrossRef
50.
Burnet M. Cancer; a biological approach. I. The processes of control. Br Med J. 1957;1(5022):779–86.PubMedCrossRef
51.
Thun MJ, Henley SJ. Tobacco. In: Schottenfeld D, Fraumeni Jr JF, editors. Cancer epidemiology and prevention. Oxford: Oxford University Press; 2006.
52.
Haiman CA, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006;354(4):333–42.PubMedCrossRef
53.
Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst. 1993;85(6):457–64.PubMedCrossRef
54.
55.
Rothman KJ, Greenland S. Modern epidemiology, vol. 2. Philadelphia: Lippencott-Raven; 1998.
56.
Hennekens C, Buring JE. Epidemiology in medicine. Boston: Little, Brown & Company; 1987.
57.
Koutros S, et al. Heterocyclic aromatic amine pesticide use and human cancer risk: results from the U.S. Agricultural Health Study. Int J Cancer. 2009;124(5):1206–12.PubMedCrossRef
58.
Blair A, et al. Reliability of reporting on life-style and agricultural factors by a sample of participants in the Agricultural Health Study from Iowa. Epidemiology. 2002;13(1):94–9.PubMedCrossRef
59.
Hoppin JA, et al. Accuracy of self-reported pesticide use duration information from licensed pesticide applicators in the Agricultural Health Study. J Expo Anal Environ Epidemiol. 2002;12(5):313–8.PubMedCrossRef
60.
Toren K, Brisman J, Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest. 1993;104(2):600–8.PubMedCrossRef
61.
Kehoe R, et al. Comparing self-reported and physician-reported medical history. Am J Epidemiol. 1994;139:813–8.PubMed
62.
Giles WH, et al. The validity of self-reported hypertension and correlates of hypertension awareness among blacks and whites within the stroke belt. Am J Prev Med. 1995;11:163–9.PubMed
63.
Vargas CM, et al. Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988–1991. Prev Med. 1997;26:678–85.PubMedCrossRef
64.
Borrell LN, Crawford ND. Disparities in self-reported hypertension in Hispanic subgroups, non-Hispanic black and non-Hispanic White adults: the National Health Interview Survey. Ann Epidemiol. 2008;18(10):803–12.PubMedCrossRef
65.
Canales S, Ganz PA, Coscarelli CA. Translation and validation of life instrument for Hispanic American cancer patients: methodological considerations. Qual Life Res. 1995;4:3–11.PubMedCrossRef
66.
Checkoway H, Pearce N, Kriebel D. Research methods in occupational epidemiology. 2nd ed. Oxford: Oxford University Press; 2004.CrossRef
Metadata
Title
Self-Reported Prior Lung Diseases as Risk Factors for Non-small Cell Lung Cancer in Mexican Americans
Authors
Michelle K. McHugh
Matthew B. Schabath
Chung-han Ho
Mei Liu
Anthony M. D’Amelio Jr.
Anthony J. Greisinger
George L. Delclos
Margaret R. Spitz
Carol J. Etzel
Publication date
01-10-2013
Publisher
Springer US
Published in
Journal of Immigrant and Minority Health / Issue 5/2013
Print ISSN: 1557-1912
Electronic ISSN: 1557-1920
DOI
https://doi.org/10.1007/s10903-012-9690-7

Other articles of this Issue 5/2013

Journal of Immigrant and Minority Health 5/2013 Go to the issue

Original Paper

Geopolitical and Cultural Factors Affecting ARV Adherence on the US-Mexico Border

Original Paper

Incidence of Type 2 Diabetes by Place of Birth in the Multi-Ethnic Study of Atherosclerosis (MESA)

Original Paper

Effects of Post-migration Factors on PTSD Outcomes Among Immigrant Survivors of Political Violence

Original Paper

Perceived Discrimination and Psychological Distress Among Asian Americans: Does Education Matter?

Original Paper

Racial and Ethnic Differences in the Immigrant Paradox in Substance Use

Original Paper

Does the Healthy Immigrant Effect Extend to Anxiety Disorders? Evidence from a Nationally Representative Study